231 related articles for article (PubMed ID: 34664813)
1. Evaluationof the New Outer Membrane Protein A Epitope-based Vaccines for Mice Model of Acinetobacter baumannii Associated Pneumonia and Sepsis Infection.
Mehdinejadiani K; Hashemi A; Bandehpour M; Rahmani H; Ranjbar MM; Yardel V; Jalali SA; Mosaffa N
Iran J Allergy Asthma Immunol; 2021 Sep; 20(5):537-549. PubMed ID: 34664813
[TBL] [Abstract][Full Text] [Related]
2. OmpW is a potential target for eliciting protective immunity against Acinetobacter baumannii infections.
Huang W; Wang S; Yao Y; Xia Y; Yang X; Long Q; Sun W; Liu C; Li Y; Ma Y
Vaccine; 2015 Aug; 33(36):4479-85. PubMed ID: 26207591
[TBL] [Abstract][Full Text] [Related]
3. In Silico Design and Evaluation of Acinetobacter baumannii Outer Membrane Protein a Antigenic Peptides As Vaccine Candidate in Immunized Mice.
Mehdinejadiani K; Bandehpour M; Hashemi A; Ranjbar MM; Taheri S; Jalali SA; Mosaffa N
Iran J Allergy Asthma Immunol; 2019 Nov; 18(6):655-663. PubMed ID: 32245309
[TBL] [Abstract][Full Text] [Related]
4. Immunoprotective potential of in silico predicted Acinetobacter baumannii outer membrane nuclease, NucAb.
Garg N; Singh R; Shukla G; Capalash N; Sharma P
Int J Med Microbiol; 2016 Jan; 306(1):1-9. PubMed ID: 26614015
[TBL] [Abstract][Full Text] [Related]
5. Immunization against multidrug-resistant Acinetobacter baumannii effectively protects mice in both pneumonia and sepsis models.
Huang W; Yao Y; Long Q; Yang X; Sun W; Liu C; Jin X; Li Y; Chu X; Chen B; Ma Y
PLoS One; 2014; 9(6):e100727. PubMed ID: 24956279
[TBL] [Abstract][Full Text] [Related]
6. Hybrid Antigens Expressing Surface Loops of ZnuD From
Qamsari MM; Rasooli I; Chaudhuri S; Astaneh SDA; Schryvers AB
Front Immunol; 2020; 11():158. PubMed ID: 32117294
[No Abstract] [Full Text] [Related]
7. Intranasal immunization protects against Acinetobacter baumannii-associated pneumonia in mice.
KuoLee R; Harris G; Yan H; Xu HH; Conlan WJ; Patel GB; Chen W
Vaccine; 2015 Jan; 33(1):260-7. PubMed ID: 24699469
[TBL] [Abstract][Full Text] [Related]
8. Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection.
Luo G; Lin L; Ibrahim AS; Baquir B; Pantapalangkoor P; Bonomo RA; Doi Y; Adams MD; Russo TA; Spellberg B
PLoS One; 2012; 7(1):e29446. PubMed ID: 22253723
[TBL] [Abstract][Full Text] [Related]
9. Mucosal immunization with purified OmpA elicited protective immunity against infections caused by multidrug-resistant Acinetobacter baumannii.
Zhang X; Yang T; Cao J; Sun J; Dai W; Zhang L
Microb Pathog; 2016 Jul; 96():20-5. PubMed ID: 27133268
[TBL] [Abstract][Full Text] [Related]
10. Immunoprotective potential of BamA, the outer membrane protein assembly factor, against MDR Acinetobacter baumannii.
Singh R; Capalash N; Sharma P
Sci Rep; 2017 Sep; 7(1):12411. PubMed ID: 28963492
[TBL] [Abstract][Full Text] [Related]
11. Prevention of nosocomial Acinetobacter baumannii infections with a conserved immunogenic fimbrial protein.
Mahmoudi Z; Rasooli I; Jahangiri A; Darvish Alipour Astaneh S
APMIS; 2020 Jul; 128(7):476-483. PubMed ID: 32445596
[TBL] [Abstract][Full Text] [Related]
12. Immunization with a 22-kDa outer membrane protein elicits protective immunity to multidrug-resistant Acinetobacter baumannii.
Huang W; Yao Y; Wang S; Xia Y; Yang X; Long Q; Sun W; Liu C; Li Y; Chu X; Bai H; Yao Y; Ma Y
Sci Rep; 2016 Feb; 6():20724. PubMed ID: 26853590
[TBL] [Abstract][Full Text] [Related]
13. Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii.
McConnell MJ; Rumbo C; Bou G; Pachón J
Vaccine; 2011 Aug; 29(34):5705-10. PubMed ID: 21679737
[TBL] [Abstract][Full Text] [Related]
14. Immunological evaluation of OMV(PagL)+Bap(1-487aa) and AbOmpA(8-346aa)+Bap(1-487aa) as vaccine candidates against Acinetobacter baumannii sepsis infection.
Badmasti F; Ajdary S; Bouzari S; Fooladi AA; Shahcheraghi F; Siadat SD
Mol Immunol; 2015 Oct; 67(2 Pt B):552-8. PubMed ID: 26277277
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Protective Efficacy of a Fused OmpK/Omp22 Protein Vaccine Candidate against Acinetobacter baumannii Infection in Mice.
Guo SJ; Ren S; Xie YE
Biomed Environ Sci; 2018 Feb; 31(2):155-158. PubMed ID: 29606195
[TBL] [Abstract][Full Text] [Related]
16. A lipopolysaccharide-free outer membrane vesicle vaccine protects against Acinetobacter baumannii infection.
Pulido MR; García-Quintanilla M; Pachón J; McConnell MJ
Vaccine; 2020 Jan; 38(4):719-724. PubMed ID: 31843268
[TBL] [Abstract][Full Text] [Related]
17. Exploitation of two siderophore receptors, BauA and BfnH, for protection against Acinetobacter baumannii infection.
Aghajani Z; Rasooli I; Mousavi Gargari SL
APMIS; 2019 Dec; 127(12):753-763. PubMed ID: 31512768
[TBL] [Abstract][Full Text] [Related]
18. Specific egg yolk antibodies (IgY) confer protection against Acinetobacter baumannii in a murine pneumonia model.
Jahangiri A; Owlia P; Rasooli I; Salimian J; Derakhshanifar E; Naghipour Erami A; Darzi Eslam E; Darvish Alipour Astaneh S
J Appl Microbiol; 2019 Feb; 126(2):624-632. PubMed ID: 30353977
[TBL] [Abstract][Full Text] [Related]
19. Development of Different Methods for Preparing
Li S; Chen DQ; Ji L; Sun S; Jin Z; Jin ZL; Sun HW; Zeng H; Zhang WJ; Lu DS; Luo P; Zhao AN; Luo J; Zou QM; Li HB
Front Immunol; 2020; 11():1069. PubMed ID: 32655550
[No Abstract] [Full Text] [Related]
20. First steps towards a vaccine against Acinetobacter baumannii.
Garcia-Quintanilla M; Pulido MR; McConnell MJ
Curr Pharm Biotechnol; 2013; 14(10):897-902. PubMed ID: 24372252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
